Chromatin/Epigenetics
Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
- Bromodomain(50)
- Aurora Kinase(63)
- DNA Methyltransferase(35)
- HDAC(210)
- Histone Acetyltransferases(78)
- Histone Demethylases(110)
- Histone Methyltransferase(240)
- HIF(102)
- JAK(173)
- MBT Domains(1)
- PARP(122)
- Pim(32)
- Protein Ser/Thr Phosphatases(34)
- RNA Polymerase(7)
- Sirtuin(77)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(246)
- MicroRNA(24)
- Protein Arginine Deiminase(7)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(44)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(1)
- METTL3(2)
- WDR5(1)
- TET Protein(2)
- HuR(1)
- SF3B1(1)
Chromatin/Epigenetics 相关产品(1617)
- GC11806β-Glycerophosphate (sodium salt hydrate)CAS: 13408-09-8纯度: >98.00%
An inhibitor of alkaline phosphatase
- GC118732,4-Pyridinedicarboxylic AcidCAS: 499-80-9纯度: >99.00%
An inhibitor of 2-oxoglutarate-dependent enzymes
- GC11990TCS-PIM-1-4aCAS: 327033-36-3纯度: >99.50%
TCS-PIM-1-4a (SMI-4a) 是一种泛 Pim 激酶抑制剂,通过激活 AMPK 来阻断 mTORC1 的活性。 TCS-PIM-1-4a 可杀死多种髓系和淋巴系细胞系(IC50 值范围为 0.8 μM 至 40 μM)。
- GC12145ENMD-2076 L-(+)-Tartaric acidCAS: 1291074-87-7纯度: >98.50%
ENMD-2076 L-(+)-Tartaric acid 是一种多靶点激酶抑制剂,对 Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1 的 IC50 为 1.86、14、58.2、15.9、92.7、70.8、56.4 nM , FGFR2, Src, PDGFRα, 分别。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11414 | GSK503 | 1346572-63-1 | >99.50% | |
A potent, selective EZH2 inhibitor | ||||
| GC11418 | MI-2 | 1271738-62-5 | >99.00% | |
An inhibitor of menin-MLL fusion protein interactions | ||||
| GC11430 | Remodelin | 1622921-15-6 | >98.00% | |
Remodelin 是 N-乙酰转移酶 10 (NAT10) 的小分子抑制剂。 | ||||
| GC11439 | MG 149 | 1243583-85-8 | >99.50% / >98.00% | |
MG 149是一种组蛋白乙酰转移酶(HAT)抑制剂,对Tip60和MOF的IC 50 值分别为74μM和47μM。 | ||||
| GC11539 | CI 976 | 114289-47-3 | - | |
An inhibitor of ACAT-1 | ||||
| GC11548 | Tankyrase Inhibitors (TNKS) 49 | - | - | |
Tankyrase inhibitor | ||||
| GC11561 | NSC 95397 | 93718-83-3 | >98.00% | |
An irreversible inhibitor of Cdc25 isoforms | ||||
| GC11578 | GSK2879552 | 1401966-69-5 | >99.50% | |
An LSD1 inhibitor | ||||
| GC11641 | Boc-Lys(Ac)-AMC | 233691-67-3 | >99.00% | |
A fluorogenic HDAC substrate | ||||
| GC11652 | CHZ868 | 1895895-38-1 | >99.00% | |
CHZ868 是一种 II 型 JAK2 抑制剂,在 EPOR JAK2 WT Ba/F3 细胞中的 IC50 为 0.17 μM。 | ||||
| GC11716 | SIRT1/2 Inhibitor IV | 14513-15-6 | >99.00% | |
Cell-permeable inhibitor of SIRT1 and SIRT2 | ||||
| GC11767 | Hydralazine HCl | 304-20-1 | >99.50% | |
An antihypertensive agent | ||||
| GC11792 | OG-L002 HCl | 1357298-75-9 | - | |
An LSD1 inhibitor | ||||
| GC11806 | β-Glycerophosphate (sodium salt hydrate) | 13408-09-8 | >98.00% | |
An inhibitor of alkaline phosphatase | ||||
| GC11873 | 2,4-Pyridinedicarboxylic Acid | 499-80-9 | >99.00% | |
An inhibitor of 2-oxoglutarate-dependent enzymes | ||||
| GC11972 | NU 9056 | 1450644-28-6 | >98.00% | |
NU 9056(1,2-双(异噻唑-5-基)二硫烷)是一种有效且选择性的Tip60(KAT5) 组蛋白乙酰转移酶(HAT)抑制剂,IC 50 值为2μM,具有抗肿瘤活性。 | ||||
| GC11990 | TCS-PIM-1-4a | 327033-36-3 | >99.50% | |
TCS-PIM-1-4a (SMI-4a) 是一种泛 Pim 激酶抑制剂,通过激活 AMPK 来阻断 mTORC1 的活性。 TCS-PIM-1-4a 可杀死多种髓系和淋巴系细胞系(IC50 值范围为 0.8 μM 至 40 μM)。 | ||||
| GC12005 | C7280948 | 587850-67-7 | >98.00% | |
A PRMT1 inhibitor | ||||
| GC12009 | HAT Inhibitor II | 932749-62-7 | >99.00% | |
An inhibitor of HAT p300 | ||||
| GC12020 | TCS 401 | 243966-09-8 | >98.00% | |
A selective PTP1B inhibitor | ||||
| GC12074 | BG45 | 926259-99-6 | >99.50% | |
A selective HDAC3 inhibitor | ||||
| GC12082 | Cantharidic Acid (sodium salt) | 1465-77-6 | - | |
A protein phosphatase inhibitor | ||||
| GC12115 | CUDC-907 | 1339928-25-4 | >99.50% | |
CUDC 是一种口服生物可利用的小分子 PI3K 和 HDAC 双重抑制剂,作用于 PI3K α 和 HDAC1 / 2 / 3 / 10,IC50 分别为 19 nm 和 1.7 nm / 5 nm / 1.8 nm / 2.8 nm .在 WSU DLCL2 细胞中评估了双功能 HDAC 和 PI3K 抑制剂 CUDC-907 的抗肿瘤活性。 | ||||
| GC12145 | ENMD-2076 L-(+)-Tartaric acid | 1291074-87-7 | >98.50% | |
ENMD-2076 L-(+)-Tartaric acid 是一种多靶点激酶抑制剂,对 Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1 的 IC50 为 1.86、14、58.2、15.9、92.7、70.8、56.4 nM , FGFR2, Src, PDGFRα, 分别。 | ||||
